389 related articles for article (PubMed ID: 33080937)
21. N-Hydroxysuccinamide functionalized iron oxide nanoparticles conjugated with 5-flurouracil for hyperthermic therapy of malignant liver cancer cells by DNA repair disruption.
Veeramani S; Chandrababu L; Rajangam I; Singh NR; Al-Humaid L; Al-Dahmash ND; Balaji R; Chandrasekar N; Hwang MT
Int J Biol Macromol; 2023 Oct; 250():126001. PubMed ID: 37532190
[TBL] [Abstract][Full Text] [Related]
22. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes.
Petters C; Thiel K; Dringen R
Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375
[TBL] [Abstract][Full Text] [Related]
23. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI.
Girard OM; Ramirez R; McCarty S; Mattrey RF
Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047
[TBL] [Abstract][Full Text] [Related]
24. Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System.
Ansari SAMK; Ficiarà E; Ruffinatti FA; Stura I; Argenziano M; Abollino O; Cavalli R; Guiot C; D'Agata F
Materials (Basel); 2019 Feb; 12(3):. PubMed ID: 30717431
[TBL] [Abstract][Full Text] [Related]
25. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications.
Etemadi H; Buchanan JK; Kandile NG; Plieger PG
ACS Biomater Sci Eng; 2021 Dec; 7(12):5432-5450. PubMed ID: 34786932
[TBL] [Abstract][Full Text] [Related]
26. GO-Functionalized Large Magnetic Iron Oxide Nanoparticles with Enhanced Colloidal Stability and Hyperthermia Performance.
Sugumaran PJ; Liu XL; Herng TS; Peng E; Ding J
ACS Appl Mater Interfaces; 2019 Jun; 11(25):22703-22713. PubMed ID: 31244027
[TBL] [Abstract][Full Text] [Related]
27. Enhancing ROS-Inducing Nanozyme through Intraparticle Electron Transport.
Yi Z; Yang X; Liang Y; Chapelin F; Tong S
Small; 2024 Feb; 20(6):e2305974. PubMed ID: 37771197
[TBL] [Abstract][Full Text] [Related]
28. Effects of biological buffer solutions on the peroxidase-like catalytic activity of Fe
Raineri M; Winkler EL; Torres TE; Vasquez Mansilla M; Nadal MS; Zysler RD; Lima E
Nanoscale; 2019 Oct; 11(39):18393-18406. PubMed ID: 31573583
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles.
Turcheniuk K; Tarasevych AV; Kukhar VP; Boukherroub R; Szunerits S
Nanoscale; 2013 Nov; 5(22):10729-52. PubMed ID: 24091568
[TBL] [Abstract][Full Text] [Related]
30. Antioxidant Iron Oxide Nanoparticles: Their Biocompatibility and Bioactive Properties.
Lee J; Lee JH; Lee SY; Park SA; Kim JH; Hwang D; Kim KA; Kim HS
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958885
[TBL] [Abstract][Full Text] [Related]
31. Chemical transformation and cytotoxicity of iron oxide nanoparticles (IONPs) accumulated in mitochondria.
Ruan L; Li H; Zhang J; Zhou M; Huang H; Dong J; Li J; Zhao F; Wu Z; Chen J; Chai Z; Hu Y
Talanta; 2023 Jan; 251():123770. PubMed ID: 35961081
[TBL] [Abstract][Full Text] [Related]
32. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
[TBL] [Abstract][Full Text] [Related]
33. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.
Pillarisetti S; Uthaman S; Huh KM; Koh YS; Lee S; Park IK
Tissue Eng Regen Med; 2019 Oct; 16(5):451-465. PubMed ID: 31624701
[TBL] [Abstract][Full Text] [Related]
34. T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.
Zhang L; Zhong X; Wang L; Chen H; Wang YA; Yeh J; Yang L; Mao H
J Magn Reson Imaging; 2011 Jan; 33(1):194-202. PubMed ID: 21182139
[TBL] [Abstract][Full Text] [Related]
35. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
36. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter.
Barbaro D; Di Bari L; Gandin V; Evangelisti C; Vitulli G; Schiavi E; Marzano C; Ferretti AM; Salvadori P
PLoS One; 2015; 10(4):e0123159. PubMed ID: 25874906
[TBL] [Abstract][Full Text] [Related]
37. Approaches on Ferrofluid Synthesis and Applications: Current Status and Future Perspectives.
Oehlsen O; Cervantes-Ramírez SI; Cervantes-Avilés P; Medina-Velo IA
ACS Omega; 2022 Feb; 7(4):3134-3150. PubMed ID: 35128226
[TBL] [Abstract][Full Text] [Related]
38. Energy Transfer from Magnetic Iron Oxide Nanoparticles: Implications for Magnetic Hyperthermia.
Tabacchi G; Armenia I; Bernardini G; Masciocchi N; Guagliardi A; Fois E
ACS Appl Nano Mater; 2023 Jul; 6(14):12914-12921. PubMed ID: 37533540
[TBL] [Abstract][Full Text] [Related]
39. 1-2 T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.
Zhang G; Zhen C; Yang J; Zhang Z; Wu Y; Che J; Shang P
J Orthop Translat; 2023 Jan; 38():126-140. PubMed ID: 36381248
[TBL] [Abstract][Full Text] [Related]
40. Arsenic removal from water using flame-synthesized iron oxide nanoparticles with variable oxidation states.
Abid AD; Kanematsu M; Young TM; Kennedy IM
Aerosol Sci Technol; 2013 Feb; 47(2):169-176. PubMed ID: 23645964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
